| People | Locations | Statistics |
|---|---|---|
| Naji, M. |
| |
| Motta, Antonella |
| |
| Aletan, Dirar |
| |
| Mohamed, Tarek |
| |
| Ertürk, Emre |
| |
| Taccardi, Nicola |
| |
| Kononenko, Denys |
| |
| Petrov, R. H. | Madrid |
|
| Alshaaer, Mazen | Brussels |
|
| Bih, L. |
| |
| Casati, R. |
| |
| Muller, Hermance |
| |
| Kočí, Jan | Prague |
|
| Šuljagić, Marija |
| |
| Kalteremidou, Kalliopi-Artemi | Brussels |
|
| Azam, Siraj |
| |
| Ospanova, Alyiya |
| |
| Blanpain, Bart |
| |
| Ali, M. A. |
| |
| Popa, V. |
| |
| Rančić, M. |
| |
| Ollier, Nadège |
| |
| Azevedo, Nuno Monteiro |
| |
| Landes, Michael |
| |
| Rignanese, Gian-Marco |
|
Aziz, Md. Abdul
in Cooperation with on an Cooperation-Score of 37%
Topics
Publications (7/7 displayed)
- 2024Optimizing Electrodeposition of Polyaniline on Various Woven Steel Mesh Sizes for Enhanced Supercapacitor Performance
- 2024Electrochemical detection of sulfite using gold nanoparticles decorated poly[2-(methacryloyloxy) ethyl] trimethylammonium chloride: kinetic and mechanistic studiescitations
- 2023A review of pharmacogenetic studies in the Bangladeshi populationcitations
- 2023Evaluation of the Association between FGFR2 Gene Polymorphisms and Breast Cancer Risk in the Bangladeshi Populationcitations
- 2023Metal Negatrode Supercapatteries: Advancements, Challenges, and Future Perspectives for High‐Performance Energy Storagecitations
- 2022TF and TCF4 gene polymorphisms are linked to autism spectrum disorder: a case–control studycitations
- 2021Physico-chemical properties and toxicological effects on plant and algal models of carbon nanosheets from a nettle fibre clonecitations
Places of action
| Organizations | Location | People |
|---|
article
A review of pharmacogenetic studies in the Bangladeshi population
Abstract
<jats:title>Abstract</jats:title><jats:p>Pharmacogenetics (PGx)-guided prescribing is an evidence-based precision medicine strategy. Although the past two decades have reported significant advancements in both the quality and quantity of PGx research studies, they are seldom done in developing countries like Bangladesh. This review identified and summarized PGx studies conducted in the Bangladeshi population by searching PubMed and Google Scholar. Additionally, a quality evaluation of the identified studies was also carried out. Eleven PGx studies were identified that looked at the effects of genetic variants on blood thinners (<jats:italic>CYP2C9</jats:italic>, <jats:italic>VKORC1</jats:italic>, and <jats:italic>ITGB3</jats:italic>), cancer drugs (<jats:italic>TPMT</jats:italic>, <jats:italic>MTHFR</jats:italic>, <jats:italic>DPYD</jats:italic>, <jats:italic>ERCC1</jats:italic>, <jats:italic>GSTP1</jats:italic>, <jats:italic>XPC</jats:italic>, <jats:italic>XRCC1</jats:italic>, <jats:italic>TP53</jats:italic>, <jats:italic>XPD</jats:italic>, and <jats:italic>ABCC4</jats:italic>), statins (<jats:italic>COQ2</jats:italic>, <jats:italic>CYP2D6</jats:italic>, and <jats:italic>CYP3A5</jats:italic>), and prednisolone (<jats:italic>ABCB1</jats:italic>, <jats:italic>CYP3A5</jats:italic>, and <jats:italic>NR3C1</jats:italic>) in the Bangladeshi population. Most studies were of low to moderate quality. Although the identified studies demonstrated the potential for PGx testing, the limited PGx literature in the Bangladeshi population poses a significant challenge in the widespread implementation of PGx testing in Bangladesh.</jats:p>